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Time to Implement Feasible Strategies
and to Monitor ResultsValentin Fuster, MD, PHDT he length of time for physicians to incorpo-rate into their daily clinical care routinesnew practice guidelines from such organiza-
tions as the American College of Cardiology and the
American Heart Association has been widely publi-
cized. However, what receives far less attention—and
may be far more damaging—is the lack of follow-up
for global health recommendations, of which there
have been approximately 30 in the past 20 years.
One of the problems is that each of these well-
intentioned global health organizations produces
different recommendations, often with ambitious
goals but with no plans to evaluate the results of
whether the strategies were implemented properly—
or implemented at all.
The global burden of disease has dramatically
shifted from communicable, maternal, perinatal, and
nutritional causes to noncommunicable diseases
(NCDs) (Fig. 1). In India alone, rapid changes in the
country’s society and lifestyles have caused NCDs to
become responsible for two-thirds of the total
morbidity burden and about 53% of total deaths (up
from 40.4% in 1990, and expected to increase to 59%
by 2015) (1). This change is an example of the wide-
spread urbanization that has occurred during the last
century. Thus, as societies shift from rural to urban
settings, major changes occur in the types of food
consumed, which often runs in parallel with an
increased sedentary lifestyle.
By 2020, heart disease and stroke will become the
leading causes of death and disability worldwide,
with the number of fatalities projected to increase to. Wiener Cardiovascular Institute, Icahn
inai, New York, New York.more than 24 million by 2030 (2). These deadly killers
no longer just affect privileged individuals and na-
tions, because more than 80% of deaths related to
cardiovascular disease worldwide now occur in low-
and middle-income countries. These diseases already
affect people from villages in India and Africa; small
towns in Chile; major cities in the United States,
China, and Europe; and everywhere in between. As
physicians, we always consider the human toll; yet,
the economic impact can be equally damaging, not
only in developed countries, but especially in devel-
oping countries that desperately need a healthy
workforce. Like many of my fellow cardiologists, I feel
a tremendous responsibility to address this burgeon-
ing global epidemic in an impactful, meaningful, and
strategic manner.
As a result, the U.S. Institute of Medicine (IOM)
formed a committee, of which I assumed the direc-
torship, to create a set of tangible recommenda-
tions that would catalyze and focus action around
this important global health problem. The result-
ing report, “Promoting Cardiovascular Health in
the Developing World,” was released in 2010 (3).
Funded by the U.S. National Heart, Lung, and Blood
Institute, it detailed the reasons behind the expo-
nential growth in cardiovascular-related illnesses,
detailed the behaviors that contribute to them, and
outlined ways to reduce the global burden of these
diseases. We produced 12 recommendations, high-
lighting a need for new tools, national policies,
and results-oriented programs. We also emphasized
collaborations among governments, global health
organizations, development agencies, and the inter-
national business community.
To me and to the other members of our committee,
this was a call to the responsibility in all of us as
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521individuals, as physicians, and as members of the
various societies—governmental, public, or private.
Thus, to counteract the global burden of cardiovas-
cular disease, we proposed 12 feasible strategies,
including a strict monitoring plan for each strategy
and a follow-up of the results. For instance, public
groups and representatives from private industry,
led by the International Food and Beverage Associa-
tion, should collaborate in a responsible manner on
strategies to reduce people’s consumption of salt,
sugar, saturated fats, and trans fats—all contributors
to risk factors for developing cardiovascular disease.
Success will require ﬁnding the responsible balance of
regulatory policies from national governments and
voluntary actions from industry, taking into account
that agricultural practices, food distribution, market-
ing systems, and cultural preferences vary across na-
tions. In addition, we emphasized the need for global
access to appropriate care. Thus, pharmaceutical and
medical technology ﬁrms, insurance companies, and
public health and aid groups should work together to
make therapies, diagnostic tools, and preventive
techniques for these diseases affordable and available
in all nations. But many developing countries do not
have the resources or infrastructure to take advantage
of certain innovations and technologies. Given the
toll that cardiovascular disease takes on each nation’s
health and productivity, nongovernmental groups
and professional health societies should advocatefor charities, private foundations, and government aid
agencies to earmark funding and other resources for
initiatives to control the epidemic worldwide.
When we formed the IOM committee, we recog-
nized the need for follow-up on our recommenda-
tions; in fact, our 12th recommendation actually
prescribed a model to report on global progress using
the World Health Organization (WHO) Monitoring
Model. Charting progress in a consistent, standard-
ized way is integral to moving ahead. It will help the
global community deﬁne goals, coordinate efforts,
communicate shared messages, take decisive action,
and know whether these efforts are effectively
reducing the burden of chronic disease. On a local
level, ideally, it will help governments identify
shortfalls in resources and recognize necessary policy
changes. Speciﬁcally, to appropriately follow-up with
our IOM 12 recommendations from 2010, we just
published a comprehensive evaluation as a special
issue of Scientiﬁc American (4). This series of chap-
ters, authored by some of the world’s foremost au-
thorities on global health and cardiovascular disease,
elaborate on the IOM’s 12 recommendations, high-
lighting 12 key examples of successful programs
having a true impact on improving cardiovascular
health in communities around the world. In other
words, the authors provide concrete examples of
programs that are working effectively on the ground,
reﬂecting global progress made since 2010, and seek
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522to prescribe a way forward. I see this as a signiﬁcant
step toward making a true difference, as I have
watched many global health recommendations fade
away from memory soon after their issuance because
no group was tracking their implementation or
effectiveness in practice. In order to move the dial on
this powerful problem, we need to hold ourselves
accountable through appropriate follow-up.
Last year, the world reached 2 signiﬁcant mile-
stones in the global response to the massive and
growing problem of NCDs. On May 27, 2013, ministers
from 194 WHO member states adopted the Global
Action Plan for the Prevention and Control of NCDs
2013 to 2020 at the 66th World Health Assembly. Two
months later, the United Nations (U.N.) Economic
and Social Council adopted a resolution requesting
that the U.N. secretary general establish an inter-
agency task force on the prevention and control of
NCDs. The task force, convened and led by WHO,
would help coordinate U.N. organization activities to
implement the initiative. The action plan outlined
9 voluntary global targets to lower the incidence ofcardiovascular disease, cancer, diabetes, and chronic
respiratory diseases and lower the rate of the pre-
mature deaths they cause by 25% within 12 years. In
our view, at the end, success of these 2 ambitious
programs will be based on how feasible the strategies
of action were, how strict their implementation was
monitored, and how accurately the follow-up was
recorded.
There is true momentum to address this problem,
which cannot be lost to distraction or apathy. This
ﬁght against the burden of cardiovascular disease,
affecting all countries and local corners of the world,
requires many physicians, specialists, and sub-
specialists. I ask you to join me in this battle by
contributing to the implementation of feasible stra-
tegies and/or monitoring results and follow-up.
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